Global Hp (High Potency) Apis Market Size 2024, Forecast To 2033
11 Mar, 2024
The hp (high potency) APIs market has witnessed robust growth, increasing from $23.39 billion in 2023 to $25.5 billion in 2024, with a compound annual growth rate (CAGR) of 9.0%. The historic period's growth is attributed to the escalating demand for oncology therapies, a heightened focus of pharmaceutical companies on manufacturing high potency APIs (hpAPIs), increased healthcare awareness and expenditure, strong economic growth in emerging markets, and growing government initiatives. Expected to continue its strong growth trajectory, the market is projected to reach $36.38 billion in 2028, maintaining a CAGR of 9.3%. Growth drivers in the forecast period include a rise in cancer cases, a growing focus on precision medicine, and an increasing aging population. Major trends involve a strategic focus on production facility expansion and mergers and acquisitions, substantial investments to enhance hpAPI production, the integration of artificial intelligence (AI) in manufacturing APIs, an emphasis on green manufacturing, and a dedication to launching new and innovative products.
Global HP (High Potency) APIs Market Key Driver
The expansion of the HP (high potency) APIs market is closely linked to the growing number of cancer cases and the concurrent rise in sales of cancer drugs. The increasing prevalence of cancer is driving heightened research and development efforts for anticancer medications, consequently fueling demand for high potency APIs. The World Health Organization's International Agency for Research on Cancer (IARC) projects a substantial increase in the global cancer burden, with an anticipated 29.5 million new cases and 16.4 million deaths by 2040. Notably, 70% of these deaths are projected to occur in middle and low-income countries. As of 2023, this surge in cancer cases is a key factor influencing the market size, with continued growth expected in 2024 and 2028.
Get A Free Sample Of The Global HP (High Potency) APIs Market ReportGlobal HP (High Potency) APIs Market Segments
The hp (high potency) apis market covered in this report is segmented –
1) By Type: Innovative HPAPI, Generic HPAPI
2) By Synthesis Type: Synthetic HPAPI, Biotech HPAPI
3) By Therapeutic Application: Oncology, Hormonal Disorder, Glaucoma, Other Therapeutic Applications
By Geography:The regions covered in the hp (high potency) apis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain
North America was the largest region in the global HP (high potency) APIs market in 2023. Middle East is expected to be the fastest growing region in the HP (high potency) APIs market report during the forecast period. The regions covered in the hp (high potency) apis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major HP (High Potency) APIs Industry Players
Merck KGaA, Pfizer, Inc, Thermo Fisher Scientific, Inc, Teva Pharmaceuticals, Lonza Group AG, Sanofi (EUROAPI), Corden Pharma International, Dr. Reddy’s Laboratories Ltd., Siegfried Holding AG, Novartis, Roche India, Arlak Biotech (India), Healthkind Labs Pvt. Ltd, Swisschem Healthcare Pvt. Ltd, Apikos Pharma, Kolaz Biotech, Cstone Pharma (China), Carsgen Therapeutics (China), Jw Therapeutics (China), Beigene(China), Takeda Pharmaceuticals (Japan), Astellas Pharma Inc (Japan), Otsuka Pharmaceutical Co, Ltd (Japan), Legend Biotech Co (China), Abbott Laboratories, Vectura Group (U.K), Corex Logistics, Dokumeds, Medpace, Labcorp, Almedis (Russia), Neuca, Farmacol, Polska Grupa Farmaceutyczna, Polpharma, Tzmo, Eli Lilly And Company, Bristol-Myers Squibb Company, Apotex, Gilead Sciences, Abbvie Inc, Hisun Usa Inc, Glaxosmithkline, Amega Biotech, Biomarin Pharmaceutical, Ferring Pharmaceuticals, Tikun Olam Cannbit, Wavelength Pharmaceuticals, Saudibio, Tabuk Pharmaceuticals, Cipla, Bayer, Adcock Ingram, Johnson & Johnson, Astrazeneca Pharmaceutical (Pty) Ltd, Eurolab, Ranbaxy (Sa) (Pty) Ltd.
Get The Full Global HP (High Potency) APIs Market Report
HP (High Potency) APIs Market Overview
High-potency APIs refer to the substances that, at very low doses, cause a biological response. Traditionally, cytotoxic substances and sex hormones like estrogen are used as examples of HPAPIs. Compared to standard APIs, highly potent active pharmaceutical ingredients HP (high potency) APIs market are nonetheless effective at considerably lower dosage levels, but their potency poses unique handling issues.
HP (High Potency) APIs Global Market Report 2023 provides data on the global hp (high potency) apis market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The hp (high potency) apis market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.